A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery
Introduction
Chitosan with excellent biodegradable and biocompatible characteristics, is a naturally occurring polysaccharide. Due to its unique polymeric cationic character and its gel and film forming properties, chitosan has been examined extensively in the pharmaceutical industry for its potential in the development of drug delivery systems (Yao et al., 1995, Illum, 1998).
Recently, the use of complexation between oppositely charged macromolecules to prepare chitosan beads (or microspheres) as a drug controlled release formulation, especially for peptide and protein drug delivery, has attracted much attention, because this process is very simple and mild (Polk et al., 1994, Liu et al., 1997). In addition, reversible physical crosslinking by electrostatic interaction, instead of chemical crosslinking, is applied to avoid possible toxicity of reagents and other undesirable effects.
Tripolyphosphate (TPP) is a polyanion, and can interact with cationic chitosan by electrostatic forces (Kawashima et al., 1985a, Kawashima et al., 1985b). Since Bodmeier et al. (1989) reported a TPP/chitosan complex can be prepared by dropping chitosan droplets into a TPP solution, many workers have explored the potential pharmaceutical usage (Shirashi et al., 1993, Sezer and Akbuga, 1995, Aydin and Akbuga, 1996, Calvo et al., 1997a, Calvo et al., 1997b, Shu and Zhu, 1999). However, the mechanical strength of these chitosan beads is very poor, so its usage in the pharmaceutical industry is still limited.
Aral and Akbuga (1998) have strengthened TPP/chitosan beads by coating sodium alginate on the bead surface to form a polyelectrolyte complex film. But the poor mechanical strength of TPP/chitosan beads still needs to be improved. Herein we report a new method to prepare TPP/chitosan beads with a more homogeneous structure. The controlled release behavior of model drugs from these beads was also investigated.
Section snippets
Materials
Chitosan was obtained from Tianbao Chitosan Co. Ltd (China), and refined twice by dissolving in dilute HAc solution and precipitating from dilute ammonia, the degree of deacetylation was 86%, Mv was 460 000. Fluorescein isothiocyanate dextran (FITC-dextran, Mw 71 200), Gelatin (type B, approx. 225 Bloom) and Sodium alginate (low viscosity) were all obtained from Sigma (USA). Coomassie brilliant blue R250 (BB, Mw 825) was purchased from Fluka A.G. (Switzerland) and used after sieving (less than
Morphology observation
Scanning electron micrographs of TPP/chitosan beads and their surface morphology are shown in Fig. 1. TPP/chitosan beads prepared by method 1 were not very spherical in shape (about 1.2–1.5 mm in size) (Fig. 1(A)), and had a rough surface with large wrinkles (Fig. 1(B)). Coating sodium alginate on these bead surfaces had dramatically improved the surface morphology (Fig. 1(C)), because sodium alginate can form a polyelectrolyte complex film on the bead surface with cationic chitosan.
Conclusions
In comparison with the conventional method (method 2(a) or 2(b)), TPP/chitosan beads prepared by the novel method (method 1) had a more homogeneous structure as a result of the more homogeneous crosslinking process, therefore the beads were strengthened greatly. The drug loading efficiency was very high (more than 90%) because during the preparation process the chitosan droplet was under coagulation conditions. Polyacids (such as sodium alginate) also can be coated on the surface of
Acknowledgements
The authors wish to express their thanks to National Natural Science Foundation of China for financial support.
References (17)
- et al.
Alternative approach to the preparation of chitosan beads
Int. J. Pharm.
(1998) - et al.
Chitosan beads for the delivery of salmon calcitonin: preparation and characteristics
Int. J. Pharm.
(1996) - et al.
Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan
J. Pharm. Sci.
(1985) - et al.
Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres
J. Control. Rel.
(1997) - et al.
Preparation of chitosan-reinforced alginate gel beads: effects of chitosan on gel matrix erosion
Int. J. Pharm.
(1993) - et al.
Controlled release of albumin from chitosan-alginate microcapsules
J. Pharm. Sci.
(1994) - et al.
Controlled release of piroxicam from chitosan beads
Int. J. Pharm.
(1995) - et al.
Preparation and evaluation of drug-containing chitosan beads
Drug Dev. Ind. Pharm.
(1989)
Cited by (406)
Biofunctional chitosan–biopolymer composites for biomedical applications
2024, Materials Science and Engineering R: ReportsNanochitosan derived from marine annelids
2023, Next Generation Nanochitosan: Applications in Animal Husbandry, Aquaculture and Food ConservationUpdate on modified chitosan frameworks and their applications for food, wastewater, toxic heavy metals, dyes treatment and cancer drug delivery
2022, Journal of Environmental Chemical EngineeringFabrication of an aprepitant nanosuspension using hydroxypropyl chitosan to increase the bioavailability
2022, Biochemical and Biophysical Research CommunicationsBioinspired tunable hydrogels: An update on methods of preparation, classification, and biomedical and therapeutic applications
2022, International Journal of Pharmaceutics